| Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers Y Tjendra, AF Al Mana, AP Espejo, Y Akgun, NC Millan, ... Archives of pathology & laboratory medicine 144 (12), 1465-1474, 2020 | 267 | 2020 |
| Review of current advances in serologic testing for COVID-19 AP Espejo, Y Akgun, AF Al Mana, Y Tjendra, NC Millan, ... American journal of clinical pathology 154 (3), 293-304, 2020 | 171 | 2020 |
| Genomic landscape of angiosarcoma: a targeted and immunotherapy biomarker analysis AP Espejo-Freire, A Elliott, A Rosenberg, PA Costa, P Barreto-Coelho, ... Cancers 13 (19), 4816, 2021 | 33 | 2021 |
| In vivo antitumor activity by dual stromal and tumor-targeted oncolytic measles viruses Y Jing, V Chavez, N Khatwani, Y Ban, AP Espejo, X Chen, JR Merchan Cancer gene therapy 27 (12), 910-922, 2020 | 11 | 2020 |
| Identification of genetic alterations by circulating tumor DNA in leiomyosarcoma: a molecular analysis of 73 patients J Arshad, P Barreto-Coelho, E Jonczak, A Espejo, G D'Amato, JC Trent Journal of Immunotherapy and Precision Oncology 3 (2), 64-68, 2020 | 9 | 2020 |
| Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate PA Costa, AP Espejo-Freire, KC Fan, TA Albini, G Pongas Leukemia & lymphoma 63 (1), 239-242, 2022 | 5 | 2022 |
| Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma. G Lagos, R Groisberg, DS Dizon, A Elliott, T Copeland, A Seeber, ... Journal of Clinical Oncology 39 (15_suppl), 11512-11512, 2021 | 5 | 2021 |
| A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas AP Espejo, JL Ramdial, BA Wilky, DA Kerr, JC Trent Rare tumors 10, 2036361318787626, 2018 | 5 | 2018 |
| A nonrandom association of breast implants and the formation of desmoid tumors PA Costa, S Marbin, BMLA Costa, AP Espejo‐Freire, EE Saul, ... The breast journal 27 (10), 768-775, 2021 | 4 | 2021 |
| Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma. T Copeland, R Groisberg, DS Dizon, A Elliott, G Lagos, A Seeber, ... Journal of Clinical Oncology 39 (15_suppl), 11555-11555, 2021 | 3 | 2021 |
| KIT resistance mutations identified by circulating tumor DNA and treatment outcomes in advanced gastrointestinal stromal tumor. S Bialick, BE Rose, AP Espejo-Freire, P Barreto Coelho, PA Costa, ... Journal of Clinical Oncology 40 (16_suppl), 11514-11514, 2022 | 2 | 2022 |
| Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: A report of two cases PA Costa, CKA Hana, NC Balaji, AF Skryd, BN Valdes, RO Minjares, ... Gastrointestinal Stromal Tumor 4, 2021 | 2 | 2021 |
| Cryoablation as an effective treatment for desmoid tumors: A single-institution case series. S Liu, B Miramontes, F Ferreira Souza, PA Costa, T Subhawong, ... Journal of Clinical Oncology 40 (16_suppl), e23543-e23543, 2022 | 1 | 2022 |
| Sorafenib treatment duration in desmoid tumors. PA Costa, I Yi, A Arora, NJ Hardy, S Bialick, AP Espejo-Freire, EE Jonczak, ... Journal of Clinical Oncology 42 (16_suppl), 11585-11585, 2024 | | 2024 |
| Characterizing patterns of mTORC1 activation across sarcoma subtypes using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database. DS Lefler, A Elliott, E Blomain, RG Maki, J Modiano, A Seeber, RF Riedel, ... Journal of Clinical Oncology 42 (16_suppl), 11544-11544, 2024 | | 2024 |
| Describing IgA Myeloma: An Immunophenotypic and Molecular Approach Y Akgun, Y Baykara, SM Hacking, J Langlie, MA Huberman, AP Espejo, ... Rhode Island Medical Journal 105 (6), 41-45, 2022 | | 2022 |
| Pan-sarcoma analysis of DNA damage response pathway alterations and deficiency. S Bialick, K Statz-Geary, A Elliott, J Abraham, P Walker, AP Espejo-Freire, ... Journal of Clinical Oncology 40 (16_suppl), 11548-11548, 2022 | | 2022 |
| Comparative effectiveness of systemic treatments in desmoid tumors. PA Costa, A Arora, H Tan, Y Fernandez, L Campoverde, P Barreto Coelho, ... Journal of Clinical Oncology 40 (16_suppl), e23534-e23534, 2022 | | 2022 |
| Heterogeneity in treatment regimens for AYA bone sarcomas: A comparison of outcomes at a single sarcoma center. AP Espejo-Freire, L Campoverde, Y Kropotova, K Statz-Geary, PA Costa, ... Journal of Clinical Oncology 40 (16_suppl), e23508-e23508, 2022 | | 2022 |
| Complete pathological response after neoadjuvant treatment in soft tissue sarcoma: A single-institution experience. P Barreto Coelho, CS Seldon, C Vazquez, B Yang, BE Rose, S Bialick, ... Journal of Clinical Oncology 40 (16_suppl), e23526-e23526, 2022 | | 2022 |
